Stock Analiz

SANUWAVE Health, Inc. SNWV

Medical/Dental Instruments · data as of November 13, 2026

$1.82Market cap $16M
Open the interactive analysis →

SANUWAVE Health, Inc. (SNWV) is a healthcare company listed in the US with a market value of about $16M. In the twelve months to September 30, 2026 it had revenue of $41M and net income of $4M, a net margin of 10.1%.

Its overall Stock Analiz score is 2.6 out of 5 (average). The strongest part is value (4/5); the weakest is shareholder returns (0/5).

Key numbers: a P/E of 3.8, a price to free cash flow of 6.0, 5-year revenue growth of 61% a year, a 5-year average ROIC of 20%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 334% above the current price.

About SANUWAVE Health

SANUWAVE Health is listed in the US and classified in medical/dental instruments. Revenue went from $738527 in 2017 to $44M in 2025, growth of about 66.7% a year. It was profitable in 1 of the last 9 years in our data. Its share count rose by 520% over three years (dilution for shareholders). It spends 3% of revenue on research and development.

Score: 2.6 / 5

Value4/5
Future growth4/5
Track record3/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • Strong R&D investment or growth above 20%

Checks not passed

  • PEG below 1.5
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • Profitable 5 years in a row
  • More cash than debt, or low debt to equity
  • Debt below 3 years of free cash flow
  • Liabilities below 60% of assets
  • Pays a dividend

Valuation

P/E (TTM)3.8
Forward P/E—
P/FCF6.0
P/S0.4
P/B5.5
EV/EBITDA27.5
PEG—
Dividend yield0.00%
FCF yield16.6%
Shareholder yield0.0%
Intrinsic value vs. price+334%

Growth and quality

Revenue growth (1 yr)35.0%
Revenue growth (5 yrs, per year)61.1%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-94.4%
ROIC (5-yr avg.)20.0%
Profitable years (of last 10)1
Years paying a dividend—

Financials, last 9 years

Fiscal yearTTM202520242023202220212020201920182017
Revenue$41M$44M$33M$20M$17M$13M$4M$2M$2M$738527
Net income$4M$12M-$33M-$26M-$10M-$27M-$31M-$10M-$12M-$6M
Free cash flow$3M$2M$2M-$5M-$18M-$7M-$13M-$6M-$4M-$2M
EPS (diluted)$0.48$1.23$-7.41$-12.19$-7.50$-18.75$-30.00$-18.75$-30.00$-15.00
Net margin10.1%26.8%-101.4%-126.5%-61.5%-209.5%-762.6%-682.3%-628.7%-749.9%
ROIC—20.0%————-579.9%———

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

What is SANUWAVE Health’s P/E ratio?

About 3.8, based on the last twelve months of diluted earnings per share.

Is SANUWAVE Health stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 334% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does SANUWAVE Health pay a dividend?

Not currently.

Is SANUWAVE Health a good stock to buy?

We do not give buy or sell advice. SANUWAVE Health scores 2.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.